zagotenemab

Home
Ligands
zagotenemab

GtoPdb Ligand ID: 10471

Synonyms: LY-3303560 | LY3303560

Comment: LY3303560 is a monoclonal antibody that selectively targets tau protein aggregates [1]. It is being developed by Eli Lilly for potential to treat Alzheimer's disease. The primary epitope for LY3303560 is located in the N-terminal region of tau.

Summary
Biological activity
Clinical data
References

No information available.

No information available.

Summary of Clinical Use
LY3303560 has progressed to Phase 2 clinical evaluation in patients with early symptomatic Alzhheimer's disease. Click here to link to ClinicalTrials.gov's full list of LY3303560 studies.

Summary of Clinical Use

LY3303560 has progressed to Phase 2 clinical evaluation in patients with early symptomatic Alzhheimer's disease. Click here to link to ClinicalTrials.gov's full list of LY3303560 studies.